Search

Your search keyword '"Reggiani F"' showing total 3 results
Start Over Author "Reggiani F" Journal molecular cancer
3 results on '"Reggiani F"'

2. An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma

Author

Davide Ambrosetti, Giovanna Damia, Riccardo Bellazzi, Elena Tagliavini, Francesca Reggiani, Elisabetta Sauta, Valentina Sancisi, Eleonora Zanetti, Federica Torricelli, Alessia Ciarrocchi, Giulia Gobbi, Giacomo Santandrea, Reggiani F., Sauta E., Torricelli F., Zanetti E., Tagliavini E., Santandrea G., Gobbi G., Damia G., Bellazzi R., Ambrosetti D., Ciarrocchi A., and Sancisi V.

Subjects
Cancer Research, Adenocarcinoma of Lung, Antineoplastic Agents, medicine.disease_cause, lcsh:RC254-282, Models, Biological, CRISPR/Cas9 screening, Hypoxia-Inducible Factor-Proline Dioxygenases, Proto-Oncogene Proteins p21(ras), Gene Knockout Techniques, medicine, Biomarkers, Tumor, KRAS, Humans, Molecular Targeted Therapy, Lung cancer, Letter to the Editor, Lung, biology, Disease Management, Genomics, HIF1A, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Hypoxia-Inducible Factor 1, alpha Subunit, medicine.anatomical_structure, Oncology, Mutation, biology.protein, Cancer research, Molecular Medicine, Adenocarcinoma, Disease Susceptibility, Functional genomics, EGLN1
Abstract

No Abstract available.

Published
2021

3. An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma.

Author

Reggiani F, Sauta E, Torricelli F, Zanetti E, Tagliavini E, Santandrea G, Gobbi G, Damia G, Bellazzi R, Ambrosetti D, Ciarrocchi A, and Sancisi V

Subjects
Adenocarcinoma of Lung drug therapy, Adenocarcinoma of Lung metabolism, Adenocarcinoma of Lung pathology, Antineoplastic Agents pharmacology, Antineoplastic Agents therapeutic use, Disease Management, Disease Susceptibility, Gene Knockout Techniques, Humans, Hypoxia-Inducible Factor 1, alpha Subunit metabolism, Hypoxia-Inducible Factor-Proline Dioxygenases metabolism, Models, Biological, Molecular Targeted Therapy, Adenocarcinoma of Lung genetics, Biomarkers, Tumor, Genomics methods, Hypoxia-Inducible Factor-Proline Dioxygenases genetics, Mutation, Proto-Oncogene Proteins p21(ras) genetics
Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results